Targeted Oncology |
The Role of JAK2 Inhibition in Polycythemia Vera
Targeted Oncology All patients lacking a clear contraindication should receive aspirin thromboprophylaxis and therapeutic phlebotomy to maintain the hematocrit below 45%. High-risk patients should be considered for treatment with cytoreductive therapies, of which ... |
from phlebotomy - Google News http://bit.ly/2o8lDAU
No comments:
Post a Comment